Claims for Patent: 10,059,714

Summary for Patent: 10,059,714

Title:	Protein kinase B inhibitors
Abstract:	The invention relates to a novel group of compounds of Formula (I) or salts thereof:
Inventor(s):	Johnson Paul David, Leach Andrew, Luke Richard William Arthur, Matusiak Zbigniew Stanley, Morris Jeffrey James
Assignee:	AstraZeneca AB
Application Number:	US15351481
Patent Claims:	3. A compound according to wherein Rrepresents —(CH)—R claim 1 , p represents 1 claim 1 , 2 or 3 claim 1 , Ris selected from phenyl claim 1 , piperidinyl claim 1 , piperazinyl claim 1 , pyrrolidinyl claim 1 , morpholinyl claim 1 , imidazolyl claim 1 , isoxazolyl claim 1 , pyrazolyl and thiazolyl and Ris optionally substituted by a single methyl group.4. A compound according to claim 1 , or a pharmaceutically acceptable salt thereof claim 1 , wherein Rrepresents hydroxyethyl.5. A compound according to claim 1 , or a pharmaceutically acceptable salt thereof claim 1 , wherein Rrepresents chloro or bromo.6. A compound according to claim 1 , or a pharmaceutically acceptable salt thereof claim 1 , wherein Rrepresents hydrogen.7. A compound according to claim 1 , or a pharmaceutically acceptable salt thereof claim 1 , wherein n is 0 or 1.8. A pharmaceutical composition comprising a compound according to claim 1 , or a pharmaceutically-acceptable salt thereof claim 1 , together with a pharmaceutically acceptable diluent or carrier.